Dataset: HDAC and aminopeptidase inhibitor treatment of myeloma cells
H929 human myeloma cells were exposed to aminopeptidase inhibitor (CHR-2797), HDAC inhibitor (CHR-3996), or a combinaion of the two...
H929 human myeloma cells were exposed to aminopeptidase inhibitor (CHR-2797), HDAC inhibitor (CHR-3996), or a combinaion of the two agents, for 24 hours. Following this treatment RNA was extracted and microarrays used to determine gene expression changes. Myeloma cells were exposed to chemotherapeutic agent for 24 hours.
- Species:
- human
- Samples:
- 12
- Source:
- E-GEOD-20405
- Updated:
- Dec.12, 2014
- Registered:
- Jul.11, 2014
Factors:
(via ArrayExpress)
Sample | DRUG TREATMENT |
---|---|
GSM511163 | Untreated cells |
GSM511163 | Untreated cells |
GSM511163 | Untreated cells |
GSM511160 | CHR3996 250 nanomolar 24 hours |
GSM511160 | CHR3996 250 nanomolar 24 hours |
GSM511160 | CHR3996 250 nanomolar 24 hours |
GSM511157 | CHR2797 1 micromolar 24 hours |
GSM511157 | CHR2797 1 micromolar 24 hours |
GSM511157 | CHR2797 1 micromolar 24 hours |
GSM511154 | CHR2797 1 micromolar + CHR3996 250 nanomolar 24 hours |
GSM511154 | CHR2797 1 micromolar + CHR3996 250 nanomolar 24 hours |
GSM511154 | CHR2797 1 micromolar + CHR3996 250 nanomolar 24 hours |